EXHIBIT 10.2Collaboration, License and Royalty Agreement • April 18th, 2002 • Schering Aktiengesellschaft • Pharmaceutical preparations
Schering AG and Stanford University to cooperate in the field of molecular imaging Berlin, November 28, 2006 - Schering AG, Germany (FSE: SCH), majority- owned by the Bayer Group, and Stanford University, California, USA have started a joint research...Joint Research Agreement • November 28th, 2006 • Schering Aktiengesellschaft • Pharmaceutical preparations
Exhibit 8.1Merger Agreement • April 18th, 2002 • Schering Aktiengesellschaft • Pharmaceutical preparations
Confidentiality Agreement between Bayer AG, Leverkusen, Bayer HealthCare AG, Leverkusen, and Schering AG, Berlin (each a “Party” and collectively the “Parties”) Purpose of the AgreementConfidentiality Agreement • November 30th, 2006 • Schering Aktiengesellschaft • Pharmaceutical preparations
Schering to collaborate with Combinature on combinatorial biosynthesis Berlin, December 11, 2003 - Schering AG, Germany (FSE: SCH, NYSE: SHR) and Combinature Biopharm AG, Germany, have signed a research agreement to apply Combinature's proprietary...Research Agreement • December 12th, 2003 • Schering Aktiengesellschaft • Pharmaceutical preparations
Confidentiality AgreementConfidentiality Agreement • April 19th, 2006 • Schering Aktiengesellschaft • Pharmaceutical preparations
EXHIBIT 4.1 Notarial Deed A.Prot. 1999/251 dated 29.12.1999 of the Notary Dr. Werner Wenger, Basel NOTARIAL DEED Partners' Agreement Negotiated at Basel, Switzerland, on the 29th (twenty-ninth) day of December 1999 (nineteen hundred and ninety-nine)....Partners' Agreement • September 27th, 2000 • Schering Aktiengesellschaft
